Predictors of galcanezumab response in a real-world study of Korean patients with migraine

被引：0
|
作者：
Kim, Seung Ae [1 ]
Lee, Mi Ji [1 ]
Jang, Hyemin [2 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [41] Real-World Economic Impact of OnabotulinumtoxinA in Patients with Chronic Migraine
    Rothrock, John
    Bloudek, Lisa
    Houle, Timothy
    Andress-Rothrock, Diane
    Hanlon, Christopher
    Varon, Sepideh
    NEUROLOGY, 2012, 78
  • [42] Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
    Rothrock, John F.
    Bloudek, Lisa M.
    Houle, Timothy T.
    Andress-Rothrock, Diane
    Varon, Sepideh F.
    HEADACHE, 2014, 54 (10): : 1565 - 1573
  • [43] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    Rothrock, J. F.
    Bloudek, L. M.
    Houle, T. T.
    Andress-Rothrock, D.
    Hanlon, C.
    Varon, S. F.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [44] PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine
    Ashina, Messoud
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Cohen, Joshua M.
    Konings, Martijn
    Tassorelli, Cristina
    Lyras, Leonidas
    Mitsikostas, Dimos-Dimitrios
    PAIN MANAGEMENT, 2021, 11 (06) : 647 - 654
  • [45] Predictors of Asthma Control and Exacerbations: A Real-World Study
    Racine, Genevieve
    Forget, Amelie
    Moullec, Gregory
    Jiao, Tianze
    Blais, Lucie
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2802 - +
  • [46] Real-world treatment experience and satisfaction among migraine patients: A descriptive survey study
    Smith, T. R.
    Hubig, L.
    Williams, E.
    Litalien, G. J.
    Harris, L.
    Powell, L. C.
    Johnson, K. M.
    Coric, V.
    Lloyd, A.
    Lo, S.
    HEADACHE, 2022, 62 : 82 - 83
  • [47] Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population
    Guerzoni, Simona
    Baraldi, Carlo
    Castro, Flavia Lo
    Cainazzo, Maria Michela
    Pani, Luca
    BRAIN AND BEHAVIOR, 2023, 13 (06):
  • [48] Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Na Young
    Hyun, Jae-Won
    Kim, Ho Jin
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [49] Effectiveness and safety of erenumab, galcanezumab and fremanezumab in migraine: real world data results
    Castano-Amores, C.
    Nieto-Gomez, P.
    Alvarez-Sanchez, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 819 - 820
  • [50] Real-world Reductions in Migraine and Headache Days for Patients With Migraine Initiating Fremanezumab in Germany
    Heinze, A.
    Totev, T.
    Krasenbaum, L.
    Terasawa, E.
    Akcicek, H.
    Hipp, J.
    Sun, R.
    Yim, E.
    Driessen, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 419 - 419
12345